Nefromed is now part of the Affidea Group
We are pleased to announce that at the end of 2024, a significant strategic milestone was achieved – Nefromed became part of the Affidea Group in the Czech Republic.
Through this acquisition, we have expanded our portfolio of healthcare services to include the following specialties:
General Practice
Dermatology
Allergology
Immunology
Diabetology
"The acquisition of Nefromed is an important step toward fulfilling our vision of providing patients with high-quality healthcare in an accessible and friendly environment. The integration of our teams and expertise opens new opportunities for expanding our services and introducing innovations that will ultimately benefit our patients. I look forward to this collaboration and to seeing where this partnership takes us." said MUDr. Amjad Bani Hani, Managing Director of Affidea Czech Republic.
We look forward to the new chapter we are beginning together.